|
1. Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006 Jan; 91(1):2-6. 2. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005 Mar; 352(12):1223-36. 3. Fritz MA, Speroff L. Clinical Gynecologic Endocrinology and Infertility. 8th ed. Baltimore: Lippincott, Williams & Wilkins. 2011; p:516, 525, 1309. 4. Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril. 2006 Feb; 85(2):277-84. 5. Saha L, Kaur S, Kumar Saha P. N-acetyl cysteine in clomiphene citrate resistant polycystic ovary syndrome: A review of reported outcomes. J Pharmacol Pharmacother. 2013 Jul-Sep; 4(3): 187-91. doi: 10.4103/0976-500X.114597 6. Wentzel P, Thunberg L, Eriksson UJ. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia. 1997 Jan; 40(1):7-14. 7. Santini MT, Cametti C, Indovina PL, Peterson SW. Menadione induces changes in the membrane electrical properties associated with downregulation of insulin receptors in human erythrocytes. Exp Hematol. 1998 Jun; 26(6):466-71. 8. Badawy A, Baker El Nashar A, El Totongy M. Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmenting ovulation in the management of unexplained infertility: a randomized double-blind controlled trial. Fertil Steril. 2006 Sep; 86(3):647-50. 9. Kilic-Okman T, Kucuk M. N-acetyl-cysteine treatment for polycystic ovary syndrome. Int J Gynaecol Obstet. 2004 Jun; 85(3):296-7. 10. Borgström L, Kågedal B, Paulsen O. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol. 1986; 31(2):217-22. 11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004 Jan; 81(1):19-25. 12. Rizk AY, Bedaiwy MA, Al-Inany HG. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril. 2005 Feb; 83(2):367-70. 13. Salehpour S, Sene AA, Saharkhiz N, Sohrabi MR, Moghimian F. N-Acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome. J Obstet Gynaecol Res. 2012 Sep; 38(9):1182-6. doi: 10.1111/j.1447-0756.2012.01844.x 14. Badawy A, State O, Abdelgawad S. N-Acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: a cross-over trial. Acta Obstet Gynecol Scand. 2007; 86(2):218-22. 15. Abu Hashim H, Anwar K, El-Fatah RA. N-acetyl cysteine plus clomiphene citrate versus metformin and clomiphene citrate in treatment of clomiphene-resistant polycystic ovary syndrome: a randomized controlled trial. J Womens Health (Larchmt). 2010 Nov; 19(11):2043-8. doi: 10.1089/jwh.2009.1920 16. Elnashar A, Fahmy M, Mansour A, Ibrahim K. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study. Fertil Steril. 2007 Aug; 88(2):406-9. 17. Oner G, Muderris II. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2011 Nov; 159(1):127-31. doi: 10.1016/j.ejogrb.2011.07.005 18. Fulghesu AM, Ciampelli M, Muzj G, Belosi C, Selvaggi L, Ayala GF, Lanzone A. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril. 2002 Jun; 77(6):1128-35.
|
